Clinical trial
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
NCT00456885 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00456885 |
|---|---|
| Title | The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women |
| Official title | The Effect of Exenatide on Body Weight, Energy Expenditure and Hunger in Obese Women Without Diabetes Mellitus |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Amylin Pharmaceuticals, LLC. Industry Eli Lilly and Company |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obesity, Impaired Glucose Tolerance |
| Intervention type | Drug |
| Interventions | exenatide, Placebo |
| Enrollment | 41 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Apr 5, 2007 |
| Last update posted | Sep 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: